A novel CpG island methylation panel predicts survival in lung adenocarcinomas

The lack of clinically useful biomarkers compromise the personalized management of lung adenocarcinomas (ADCs); epigenetic events and DNA methylation in particular have exhibited potential value as biomarkers. By comparing genome-wide DNA methylation data of paired lung ADCs and normal tissues from...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Pingzhao, Yang, Xiaohua, Wang, Jianhua, Wang, Shichang, Ren, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6607393/
https://www.ncbi.nlm.nih.gov/pubmed/31423161
http://dx.doi.org/10.3892/ol.2019.10431

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6607393/
https://www.ncbi.nlm.nih.gov/pubmed/31423161
http://dx.doi.org/10.3892/ol.2019.10431

Ejemplares similares